ZTS · 8-K · 20261105PR000048

Market Demand Trends

Zoetis Inc. · 2026-11-05 · Importance 37 · Surprise 32

In the third quarter of 2026, Zoetis's U.S. revenue declined 6% to $1.246 billion, while International revenue grew 4% to $1.116 billion. U.S. companion animal revenue fell 8%, with the company attributing the decline to macro-driven price sensitivity, dermatology competition, and generic competition; U.S. livestock revenue increased 5%, supported by cattle, swine, and poultry. International companion animal revenue rose 1% reported and was flat organically, while International livestock grew 8% reported and 9% organically, driven by cattle and fish. For the quarter, fish revenue increased 23% reported (18% organic operational), and China revenue increased 20% reported (14% organic operational).

Key facts

• Zoetis Inc. said U.S. Livestock revenue increased 5% on both reported and organic operational bases, supported by strength across cattle, swine, and poultry. source
• Zoetis Inc. said International Livestock revenue increased 8% reported and 9% organic operational, driven by growth in cattle and fish. source
• Zoetis Inc. said International Companion Animal revenue increased 1% reported and was flat organic operational, led by parasiticides and osteoarthritis pain, partly offset by lower sales of key dermatology products. source
• Zoetis Inc. said third-quarter Companion Animal performance faced continued pressure, partially offset by growth in Livestock and Diagnostics. source